期刊文献+

原发于睾丸和纵隔生殖细胞恶性肿瘤预后因素分析 被引量:3

Prognostic Factors in Testicular and Mediastinum Primary Germ Cell Tumor
原文传递
导出
摘要 [目的]探讨原发于睾丸和纵隔生殖细胞恶性肿瘤的临床特征、生存率及预后影响因素。[方法]回顾性分析1990至2000年收治的22例原发于睾丸和19例原发于纵隔的生殖细胞肿瘤患者的临床资料,以无疾病进展时间和总生存率为主要观察目标,进行预后评估。[结果]睾丸和纵隔生殖细胞肿瘤患者无疾病进展时间分别为62个月和19个月,10年总生存率分别为60.0%和13.3%(P=0.019)。Cox比例风险模型多因素分析结果显示:病理类型和临床分期是影响预后的主要因素。[结论]睾丸生殖细胞瘤患者的预后明显高于纵隔生殖细胞瘤患者,需要进一步探讨如何提高纵隔生殖细胞瘤的治疗效果。 [ Purpose ] To study the clinical characteristics, overall survival and prognostic factors in testicular and mediastinum primary germ cell tumor. [Methods] The dinical data from 1990 to 2000 were retrospectively reviewed, including 22 cases with primary testicular germ cell tumor and 19 cases with primary mediastinum germ cell tumor. Progression free survival (PFS) and overall survival (OS) were the primary objectives to assess prognosis. [Results] For testicular germ cell tumor and mediastinum germ cell tumor, the PFS was 62 months and 19 months; 10 years' OS, 60.0% and 13.3%, respectively, P=0.019. Cox model multivariate analysis indicated that the pathologic type and staging were closely associated with prognosis. [Conclusion] Prognosis of primary testicular germ cell tumor is much better than that of mediastinum germ cell tumor. Improving the treatment efficacy of mediastinum germ cell tumor still need further study.
出处 《肿瘤学杂志》 CAS 2008年第8期673-676,共4页 Journal of Chinese Oncology
关键词 生殖细胞瘤 睾丸 纵隔 生存率 预后 germinoma testis mediastinum survival prognosis
  • 相关文献

参考文献6

  • 1滕梁红,卢德宏,徐庆中,付永娟,杨虹,贺志立.OCT4、CD117、CD30在生殖细胞肿瘤中的表达及鉴别诊断意义[J].中华病理学杂志,2005,34(11):711-715. 被引量:27
  • 2Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer[J]. Eur Urol, 2005, 48(6): 885-894.
  • 3沈益君,叶定伟.腹膜后淋巴结清扫术在睾丸生殖细胞肿瘤中的意义[J].国外医学(泌尿系统分册),2005,25(4):477-480. 被引量:2
  • 4Sonpavde G, Hutson TE, Roth B J, et al. Management of recurrent testicular germ cell tumors[J]. Oncologist, 2007, 12(1): 51-61.
  • 5Ugo D, Giovanni R, Michele A, et al. PhaseⅡ study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor[J]. Eur Urol, 2006, 50(5):1032-1039.
  • 6Xu Q, Pearce MS, Parker L. Incidence and survival for testicular germ cell tumor in young males: a report from the Northern Region Young Person's Malignant Disease Registry, United Kingdom[J].Urol Oncol,2007,25(1):32-37.

二级参考文献39

  • 1Okamot K, Okazawa H, Okuda A, et al. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell, 1990, 60:461472.
  • 2Rosner MH, Vigano MA, Ozato K, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature, 1990, 345:686-692.
  • 3Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod, 2000,6:999-1004.
  • 4Jones TD, Ulbright TM, Eble JN, et al. OCT4 staining in testicular tumors:a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol, 2004, 28:935-940.
  • 5Cheng L, Thomas A, Roth LM, et al. OCT4, A novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol, 2004, 28: 1341-1346.
  • 6Hattab EM, Tu PH, Wilson JD, et al. OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol, 2005, 29:368-371.
  • 7Looijenga LH, Stoop H, de Leeuw HP, et al. POUSF1 (0CT3/4)identifies cells with plufipotent potential in human germ cell tumors.Cancer Res, 2003, 63:2244-2250.
  • 8Rosai J. Ackerman's surgical pathology. 8th ed. St. Louis: Mosby,1996. 1495.
  • 9Vliagoftis H, Worobec AS, Metcalfe DD. The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol, 1997,100:435 -440.
  • 10Kemmer K, Corless CL, Fletcher JA, et al. KIT mutation are commom in testicular seminomas. Am J Pathol, 2004, 164:305-313.

共引文献27

同被引文献14

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部